Higher Mutational Burden Is an Independent Predictor of Shorter Time to First Treatment in Untreated Chronic Lymphocytic Leukemia Patients

被引：0
|
作者：
Mikhaleva, Mariia [1 ,2 ]
Tyekucheva, Svitlana [3 ,4 ]
Mashima, Kiyomi [1 ,5 ]
Fernandes, Stacey M. [1 ]
Davids, Matthew S. [1 ,5 ]
Brown, Jennifer R. [1 ,5 ]
机构：
[1] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA
[2] Russian Res Inst Hematol & Transfusiol, St Petersburg, Russia
[3] Dana Farber Canc Inst, Dept Data Sci, Boston, MA 02115 USA
[4] Harvard TH Chan Sch Publ Hlth, Dept Biostat, Boston, MA USA
[5] Harvard Med Sch, Dept Med, Boston, MA 02115 USA
来源：
BLOOD | 2023年 / 142卷
关键词：
D O I：
10.1182/blood-2023-173738
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：4
相关论文
共 50 条
  • [1] The time to first treatment is an independent predictor of overall survival in chronic lymphocytic leukemia
    Morabito, Fortunato
    Tripepi, Giovanni
    Mauro, Francesca Romana
    Laurenti, Luca
    Reda, Gianluigi
    Moia, Riccardo
    Condoluci, Adalgisa
    Vincelli, Iolanda
    Chiarenza, Annalisa
    Vigna, Ernesto
    Martino, Enrica Antonia
    Bruzzese, Antonella
    Mezzatesta, Sabrina
    Laureana, Roberta
    Cutrona, Giovanna
    Di Raimondo, Francesco
    Fronza, Gilberto
    Zucchetto, Antonella
    Bomben, Riccardo
    Rossi, Francesca Maria
    Olivieri, Jacopo
    Zaja, Francesco
    Rossi, Davide
    Gaidano, Gianluca
    Del Principe, Maria Ilaria
    Ilariucci, Fiorella
    Del Poeta, Giovanni
    Ferrarini, Manlio
    Neri, Antonino
    Gattei, Valter
    Gentile, Massimo
    [J]. AMERICAN JOURNAL OF HEMATOLOGY, 2023, 98 (07) : E157 - E160
  • [2] HYPOGAMMAGLOBULINEMIA IS A STRONG PREDICTOR OF TIME TO FIRST TREATMENT IN CHRONIC LYMPHOCYTIC LEUKEMIA
    Reda, G.
    Cassin, R.
    Levati, G. V.
    Fattizzo, B.
    Mattiello, V.
    Giannarelli, D.
    Barcellini, W.
    Cortelezzi, A.
    [J]. HAEMATOLOGICA, 2017, 102 : 423 - 423
  • [3] Serum soluble CD23 levels are an independent predictor of time to first treatment in chronic lymphocytic leukemia
    Pineyroa, Juan A.
    Magnano, Laura
    Rivero, Andrea
    Rivas-Delgado, Alfredo
    Nadeu, Ferran
    Correa, Juan Gonzalo
    Gine, Eva
    Villamor, Neus
    Filella, Xavier
    Colomer, Dolors
    Lopez, Monica
    Lopez-Oreja, Irene
    Costa, Dolors
    Aymerich, Marta
    Bea, Silvia
    Lopez-Guillermo, Armando
    Campo, Elias
    Delgado, Julio
    Mozas, Pablo
    [J]. HEMATOLOGICAL ONCOLOGY, 2022, 40 (04) : 588 - 595
  • [4] Large genomic aberrations detected by SNP array are independent prognosticators of a shorter time to first treatment in chronic lymphocytic leukemia patients with normal FISH
    Mian, M.
    Rinaldi, A.
    Mensah, A. A.
    Rossi, D.
    Ladetto, M.
    Forconi, F.
    Marasca, R.
    Uhr, M.
    Stussi, G.
    Kwee, I.
    Cavalli, F.
    Gaidano, G.
    Zucca, E.
    Bertoni, F.
    [J]. ANNALS OF ONCOLOGY, 2013, 24 (05) : 1378 - 1384
  • [5] Multivariable Model for Time to First Treatment in Patients With Chronic Lymphocytic Leukemia
    Wierda, William G.
    O'Brien, Susan
    Wang, Xuemei
    Faderl, Stefan
    Ferrajoli, Alessandra
    Do, Kim-Anh
    Garcia-Manero, Guillermo
    Cortes, Jorge
    Thomas, Deborah
    Koller, Charles A.
    Burger, Jan A.
    Lerner, Susan
    Schlette, Ellen
    Abruzzo, Lynne
    Kantarjian, Hagop M.
    Keating, Michael J.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (31) : 4088 - 4095
  • [6] Cost burden of first-line treatment failure in patients with chronic lymphocytic leukemia
    Lafeuille, Marie-Helene
    Wang, Song
    Lefebvre, Patrick
    Senbetta, Mekre
    Emond, Bruno
    Romdhani, Hela
    [J]. LEUKEMIA & LYMPHOMA, 2017, 58 : 99 - 100
  • [7] ANALYSIS OF TIME TO FIRST TREATMENT IN CHRONIC LYMPHOCYTIC LEUKEMIA
    Giordano, A.
    Curci, P.
    Rizzi, R.
    Perrone, T.
    Rossi, A. Russo
    Cimmino, A.
    Mestice, A.
    De Candia, M. S.
    Gagliardi, V. P.
    Albano, F.
    Specchia, G.
    [J]. HAEMATOLOGICA, 2015, 100 : 79 - 79
  • [8] XPO1 Mutations May Identify Binet. Chronic Lymphocytic Leukemia Patients with Shorter Time to First Treatment
    Moia, Riccardo
    Favini, Chiara
    Sagiraju, Sruthi
    Spina, Valeria
    Bruscaggin, Alessio
    Rasi, Silvia
    De Paoli, Lorenzo
    Deambrogi, Clara
    Schipani, Mattia
    Kodipad, Ahad Ahmed
    Rossi, Davide
    Gaidano, Gianluca
    [J]. BLOOD, 2019, 134
  • [9] Surrogate molecular markers for IGHV mutational status in chronic lymphocytic leukemia for predicting time to first treatment
    Morabito, Fortunato
    Cutrona, Giovanna
    Mosca, Laura
    D'Anca, Marianna
    Matis, Serena
    Gentile, Massimo
    Vigna, Ernesto
    Colombo, Monica
    Recchia, Anna Grazia
    Bossio, Sabrina
    De Stefano, Laura
    Maura, Francesco
    Manzoni, Martina
    Ilariucci, Fiorella
    Consoli, Ugo
    Vincelli, Iolanda
    Musolino, Caterina
    Cortelezzi, Agostino
    Molica, Stefano
    Ferrarini, Manlio
    Neri, Antonino
    [J]. LEUKEMIA RESEARCH, 2015, 39 (08) : 840 - 845
  • [10] Economic burden of treatment failure in chronic lymphocytic leukemia patients
    Wang, Song
    Lafeuille, Marie-Helene
    Lefebvre, Patrick
    Romdhani, Hela
    Emond, Bruno
    Senbetta, Mekre
    [J]. CURRENT MEDICAL RESEARCH AND OPINION, 2018, 34 (06) : 1135 - 1142
12345